| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 45.086 | 39.799 | 32.750 | 134.525 | 192.806 | 192.834 | 201.994 |
| Total Income - EUR | - | - | - | 45.341 | 40.894 | 32.983 | 134.533 | 192.922 | 193.378 | 202.672 |
| Total Expenses - EUR | - | - | - | 2.889 | 6.517 | 29.497 | 69.489 | 109.349 | 130.823 | 146.097 |
| Gross Profit/Loss - EUR | - | - | - | 42.452 | 34.377 | 3.486 | 65.044 | 83.573 | 62.554 | 56.575 |
| Net Profit/Loss - EUR | - | - | - | 41.100 | 33.160 | 3.310 | 63.908 | 81.876 | 60.915 | 51.181 |
| Employees | - | - | - | 0 | 0 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - U1 Medicine S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 2.378 | 1.384 | 4.491 | 256.802 | 264.591 | 279.383 | 262.049 |
| Current Assets | - | - | - | 39.169 | 32.434 | 11.617 | 23.150 | 29.080 | 22.832 | 14.102 |
| Inventories | - | - | - | 0 | 0 | 3.659 | 4.527 | 5.640 | 5.623 | 6.503 |
| Receivables | - | - | - | 2.552 | 0 | 222 | 1.859 | 931 | 7.260 | 229 |
| Cash | - | - | - | 36.617 | 32.434 | 7.737 | 16.763 | 22.509 | 9.949 | 7.370 |
| Shareholders Funds | - | - | - | 41.105 | 33.211 | 14.817 | 78.397 | 160.516 | 200.929 | 199.636 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 443 | 607 | 1.291 | 201.555 | 133.155 | 99.041 | 74.936 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 2.245 | 1.579 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - U1 Medicine S.r.l.